Ilaprazole is a proton pump inhibitor used in the treatment of acid-related gastrointestinal conditions such as gastroesophageal reflux disease, dyspepsia, and peptic ulcer disease. By irreversibly binding… Read more
![Chemical structure of (1-(6-(1H-Pyrrol-1-yl)-1H-benzo[d]imidazol-2-yl)-4-methoxy-3-methylpyridin-1-ium-2-yl)methanethiolate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2285346-40-7-1-6-1H-Pyrrol-1-yl-1H-benzodimidazol-2-yl-4-methoxy-3-methylpyridin-1-ium-2-ylmethanethiolate.png&w=3840&q=75)

![Chemical structure of 1-((4-Methoxy-3-methylpyridin-2-yl)methyl)-2-(((4-methoxy-3-methylpyridin-2-yl)methyl)thio)-5-(1H-pyrrol-1-yl)-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1360824-56-1-1-4-Methoxy-3-methylpyridin-2-ylmethyl-2-4-methoxy-3-methylpyridin-2-ylmethylthio-5-1H-pyrrol-1-yl-1H-benzodimidazole.png&w=3840&q=75)
![Chemical structure of 1-(6-(1H-Pyrrol-1-yl)-1H-benzo[d]imidazol-2-yl)-2,3-dimethylpyridin-1-ium-4-olate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2285346-39-4-1-6-1H-Pyrrol-1-yl-1H-benzodimidazol-2-yl-23-dimethylpyridin-1-ium-4-olate.png&w=3840&q=75)
![Chemical structure of 1-(6-(1H-Pyrrol-1-yl)-1H-benzo[d]imidazol-2-yl)-4-methoxy-3-methylpyridin-1-ium-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2285346-38-3-1-6-1H-Pyrrol-1-yl-1H-benzodimidazol-2-yl-4-methoxy-3-methylpyridin-1-ium-2-carboxylate.png&w=3840&q=75)



![Chemical structure of 5-(1H-Pyrrol-1-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1018229-53-2-5-1H-Pyrrol-1-yl-13-dihydro-2H-benzodimidazol-2-one.png&w=3840&q=75)
![Chemical structure of 5-(1H-Pyrrol-1-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-thione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F172152-53-3-5-1H-Pyrrol-1-yl-13-dihydro-2H-benzodimidazole-2-thione.png&w=3840&q=75)








































Ilaprazole is a proton pump inhibitor used in the treatment of acid-related gastrointestinal conditions such as gastroesophageal reflux disease, dyspepsia, and peptic ulcer disease. By irreversibly binding to the H+/K+-ATPase enzyme in gastric parietal cells, this benzimidazole derivative effectively reduces gastric acid secretion. The ilaprazole category includes a comprehensive range of reference standards, including the active pharmaceutical ingredient, identified process-related impurities, and degradation products such as sulfone and desoxy derivatives. Pharmaceutical laboratories utilize these high-quality reference standards for impurity profiling, analytical method validation, and rigorous quality control testing. Furthermore, stable isotope labelled compounds, such as deuterium-labelled analogues, are available to serve as internal standards in mass spectrometry-based bioanalytical assays. These materials are essential for ensuring data accuracy, regulatory compliance, and the reliable quantification of the drug and its metabolites throughout pharmaceutical research and development.